New azetidinone cholesterol absorption inhibitors

Bibliography

• EARL J, KIRKPATRICK P: Fresh from the pipeline: ezetimibe. Nat. Rev. Drug Discovery (2003) 2:97-98.
   PubMedGoogle Scholar
• CLADER JW: The discovery of ezetimibe: a view from outside the receptor J. Med. Chem. (2004) 47:1-9.
   PubMed Web of Science ®Google Scholar
• SLISKOVIC DR, PICARD JA, KRAUSE BR: ACAT inhibitors: the search for a novel effective treatment of hypercholesterolemia and atherosclerosis. Prog. Med. Chem. (2002) 3:121-171.
   Google Scholar
• BURNETT DA, CAPLEN MA, DAVIS HR, BURRIER JRR, CLADER JW: 2-Azetidinones as inhibitors of cholesterol absorption. J. Med. Chem. (1994) 37:1733-1736.
   PubMed Web of Science ®Google Scholar
• CLADER JW, BURNETT DA, CAPLEN MA et al.: 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. J. Med. Chem. (1996) 39:3684-3693.
   PubMed Web of Science ®Google Scholar
• SALISBURY BG, DAVIS HR, BURRIER RE et al.: Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis (1995) 115:45-63.
   PubMed Web of Science ®Google Scholar
• ROSENBLUM SB, HUYNH T, AFONSO A et al.: Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)- (3S)-hydroxypropyl]-(4S)(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J. Med. Chem. (1998) 41:973-980.
   PubMed Web of Science ®Google Scholar
• BURNETT DA: β-Lactam cholesterol absorption inhibitors. Curr. Med. Chem. (2004) 11:1873-1887.
   PubMed Web of Science ®Google Scholar
• CLADER JW: Ezetimibe and other azetidinone cholesterol absorption inhibitors. Curr. Top. Med. Chem. (2005) 5:243-256.
   PubMed Web of Science ®Google Scholar
• XU X, FU R, CHEN J et al.: Ezetimibe analogs with a reorganized azetidinone ring: design, synthesis and evaluation of cholesterol absorption inhibition. Bioorg. Med. Chem. Lett. (2007) 17:101-104.
   PubMed Web of Science ®Google Scholar
• KVÆRNO L, WERDER M, HAUSER H, CARREIRA EM: Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption. J. Med. Chem. (2005) 48:6035-6053.
   PubMed Web of Science ®Google Scholar
• GARCIE-CALVO M, LISNOCK J, BULL HG et al.: The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). PNAS (2005) 102:8132-8137.
   PubMedGoogle Scholar
• HUFF MW, POLLEX RL, HEGELE RA: NPC1L1: Evolution from pharmacological target to physiological sterol transporter. Artherioiscler. Throm. Vasc. Biol. (2006) 26:2433-2438.
   PubMed Web of Science ®Google Scholar
• Kramer W, GIRBIG F, CORSIERO D et al.: Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J. Biol. Chem. (2005) 280:1306-1320.
   PubMed Web of Science ®Google Scholar
• LABONTE ED, HOWLES PN, GRANHOLM NA et al.: Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochimica et Biophysica ACTA (2007), web released.
   Google Scholar
• KVÆRNO L, RITTER T, WERDER M, HAUSER H, CARRIEIRA EM: An in vitro assay for evaluation of small-molecule inhibitors of cholesterol absorption. Angew. Chem. Int. Ed. (2004) 43:4653-4656.
   PubMed Web of Science ®Google Scholar
• YU L, GUPTA S, XU F et al.: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J. Biol. Chem. (2005) 280:8742-8747.
   PubMed Web of Science ®Google Scholar
• VAN HEEK M, FRANCE CF, COMPTON DS et al.: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH 53285, in the rat and rhesus monkey through identification of the active metabolites of SCH 48461. J. Pharm. Exper. Ther. (1997) 283:157-163.
   PubMed Web of Science ®Google Scholar
• VACCARO WD, SHER R, DAVIS HR: Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors. Bioorg. Med. Chem. Lett. (1998) 8:35-40.
   PubMedGoogle Scholar
• VAN HEEK M et al.: Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH 58235, and its glucuronide, SCH 60663. British J. Pharm. (2000) 129:1748-1754.
   PubMed Web of Science ®Google Scholar
• VACCURO WD, DAVIS HR: Sugar-substituted azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar. Bioorg. Med. Chem. Lett. (1998) 8:313-318.
   PubMedGoogle Scholar
• HAWES BE, O'NEILL KA, YAO X: In vivo responsiveness to ezetimibe correlates with Niemann–Pick C1-like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Mol. Pharmacol. (2007) 71:19-29.
   PubMed Web of Science ®Google Scholar
• VACCARO WD, SHER R, DAVIS HR et al.: Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors. Bioorg. Med. Chem. Lett. (1998) 8:319-322.
   PubMedGoogle Scholar
• ROSENBLUM SB, HUYNH T, AFONSO A, DAVIS HR: Synthesis of 3-arylpropenyl, 3-arylpropynyl, 3-arylpropoyl 2-azetidinones as cholesterol absorption inhibitors: application of the palladium-catalyzed arylation of alkenes and alkynes. Tetrahedron (2000) 56:5735-5742.
   Web of Science ®Google Scholar
• DUGAR S, CLADER JW, CHAN T, DAVIS H Jr: Substituted 2-azaspiro[5,3]nonan-1-ones as potent cholesterol absorption inhibitors: defining a binding conformation of SCH 48461. J. Med. Chem. (1995) 38:4875-4877.
   PubMed Web of Science ®Google Scholar
• MCKITTRICK BA, MA K, HUIE K et al.: Synthesis of C3-heteroatom-substitiuted azetidines that display potent cholesterol absorption inhibitory activity. J. Med. Chem. (1998) 41:752-759.
   PubMed Web of Science ®Google Scholar
• KIRKUP MP, RIZVI R, SHANKAR BB et al.: (-)-SCH57939: synthesis and pharmacological properties of a potent, metabolically stable absorption inhibitor. Bioorg. Med. Chem. Lett. (1996) 6:2069-2072.
   Web of Science ®Google Scholar
• SHANKER BB, KIRKUP MP, MCCOMBIE SW, CLADER JW, GANGULY AK: Synthesis of an optically pure 3-unsubstituted β-lactam using an asymmetric reformasky reaction and its convertion to cholesterol absorption inhibitors. Tetrahedron Lett. (1996) 37:4095-4098.
   Google Scholar
• GOTTO AM Jr, FARMER JA: Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nat. Clin. Pract. Cardiovasc. Med. (2006) 3:664-672.
   PubMedGoogle Scholar